LOS ANGELES, CA / ACCESSWIRE / September 18, 2020 / Decision Diagnostics Corp. (OTC PINK: DECN) www. decisiondiagnostics. co, a world-leading manufacturer and distributor of diabetic control strips designed to work with legacy glucometers through its subsidiary Pharma Tech Solutions, Inc. , today announced the final touch of its Covid-19 Saliva Swift kits for overseas use, as well as its costs to the global market. The overseas release of the product is expected to begin on September 26, 2020 and last for several weeks. .
As stated in a previous announcement, Genviro! The Covid-19 Saliva Swift Kits have completed a series of rigorous checks at the company’s production and product progression plant in Daegu, Korea. As a first step, we will offer 3 retail products for foreign professional use: Genviro! Swift Kit Saliva adding 1 control strip, interface sleeve adapter, saliva collection container, diluent, packaging inserts and will retail for $ 8. 95 wholesale with an MSRP of $ 29. 95; the Genviro! Swift meter kit that will come with 1 meter for up to one hundred verification readings, an automated instructional video, which can also be viewed at www. pharmatechdirect. com, a meter user manual, and a package insert. The meter will wholesale for $ 19. 95 with an MSRP of $ 39. 95 and will come with an owner’s manual, a leaflet, and the aforementioned DVD containing the company’s GenViro! Instructional video in English, with subtitles in 4 other languages, Russian, German, French and Spanish. Finally, the third product will be our Genviro! The Swift Verify Kit will come with 1 check strip, an interface sleeve adapter, and a leaflet, and is designed to provide a Covid-19 follow-up check if desired. The Swift Verify Kit will retail for $ 6. 95 in bulk with an MSRP of $ 24. 95.
“With our September 26 target date to have our first dealer order in position and scheduled delivery in a later time, the changes we’re making are the final stages of foreign marketing,” said CEO Keith Berman. “We have created a “skinny” edition of the full Swift kit that we call Verify for possible errors in the component of the professionals who manage the original check, or in the rare case in which the check is inconclusive, as well as to help other people who, for any reason, like the check manager to bring more peace of mind that will bring a result for now. “
The Swift kit counter can provide a positive or negative result in about 10 seconds and will allow tests to be performed anytime, anywhere.
Decision Diagnostics Corp. es the world’s leading manufacturer and distributor of diabetic control strips designed to paint on older glucometers. DECN products are designed to successfully and cost-effectively paint safe glucometers that are already used in nearly 7. 5 million diabetics worldwide. Check strips are already in the latter stages of development, DECN products compete globally with classic brands that lately sell more than 71% of a house check market value of more than $15 billion. On September 26, 2020, the company plans to launch its foreign package versions of its GenViro!Swift Kit and Swift Counter, yet to be in the United States or Puerto Rico. Emergency Exemptions (U. S. A. ) are ongoing with the U. S. FDA. But it’s not the first time
Forward-looking statements:
In this press release, the Company’s forward-looking statements, which are based on the management’s existing expectations and assumptions as of September 17, 2020, relating to the Company’s operations and performance, prospects, existing factors, economy and other long-term situations and long-term forecasts. events, cases and results.
CONTACT INFORMATION:
SOURCE: Decision Diagnostics Corp.